Egypt registers first-half primary surplus of EGP 3.2 billion    ITFC approves $2.6 billion financing for Egypt    Hitachi to connect Gulf of Suez wind farm with Egypt national power grid    Egypt works on charting cooperation strategies with international institutions for 5 years: Al-Mashat    Maha karara joins AAIB as Head of Corporate Communications, Sustainability    Over 2.4 million newborns examined for hearing impairment: Health Ministry    Netflix releases trailer of Arab adaption of 'Perfect Strangers' film    Balqees to headline concert celebrating launch of streaming giant LIVENow in MENA    Sawsan Badr to be honoured at Aswan Women Film Festival    Al-Sisi follows up on 'Great Transfiguration Project' in St. Catherine    Cairo, London stress need to strengthen cooperation to face climate change    Foreigners account for 22.6% of Egypt's T-bills issuances in 1H 2021: CBE    MP Abdel Hady Al-Qasby calls government to facilitate and support NGOs    Egypt's ambassador to Italy passes away    Egypt confirms readiness to help African countries face terrorism and extremism    An estimated 235 million people needed humanitarian assistance and protection in 2021, an increase of 40% compared to 2020: IOM Egypt    Egypt, DRC discuss water cooperation during WYF    Egypt, DR Congo discuss boosting bilateral cooperation during WYF    Cameroonian police probe assault on three Algerian journalists covering AFCON    Pharaohs start AFCON 2021 campaign with fierce clash against Nigeria    Foreign Ministry opens capacity building course for French-speaking African diplomats    BRICS development bank admits Egypt as new member    Nermien Ismail Schools opens a new campus in O'West    Netherlands Embassy, E7kky Magazine celebrate success of 21 Egyptian women    Women make up 45% of Egyptian Atomic Energy Authority staff    Yas Island hosts travel partners at Formula 1 Etihad Airways Abu Dhabi Grand Prix 2021    Olaf Scholz becomes Germany's new leader, ending Merkel 16-year historic era    Egypt's trade with Nile basin countries climbs 26% y-o-y in 9 months    The unvaccinated prohibited from entry to Egypt state institutions starting December 1    Egypt's iron and steel exports jump 197% in 8 months    Ethiopia halts work at its embassy in Egypt for 'economic reasons'    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Russia says it's in sync with US, China, Pakistan on Taliban    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    Brazil calls up 8 EPL players for World Cup qualifying    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Sisi calls on House, Senate to commence second legislative sessions on 3, 5 October    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    Qa'a play showing at Lycee El Horreya Theatre, Alexandria is a must go    On International Museum Day, Egypt opens two new museums at Cairo Airport    Old Cairo's Al-Fustat will be revamped on Egyptian President's directives    

Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.

BREAKING: Moderna coronavirus vaccine almost 95% effective; early trial shows
Published in Amwal Al Ghad on 16 - 11 - 2020

Moderna Inc announced on Monday its coronavirus vaccine candidate was 94.5 percent effective, becoming the second U.S. company after Pfizer to add growing confidence that vaccines can help end the pandemic.
The news comes a week after Pfizer and BioNTech said their vaccine was more than 90 percent effective.
The results for both Moderna and Pfizer- BioNTech vaccines come from interim analyses of large clinical studies.
In the Moderna study there were 30,000 volunteers, of which half got two doses of the vaccine 28 days apart, and the other half had two shots of a placebo on the same schedule.
The results indicate the vaccine was inducing the kind of immune response that protects people if they were exposed to the coronavirus, the company added.
"This positive interim analysis from our Phase 3 study has given us the first clinical validation that our vaccine can prevent COVID-19 disease, including severe disease," Stéphane Bancel, chief executive officer of Moderna, said in a statement.
Both the Moderna and Pfizer vaccines are using the same technology to make their vaccines. This technology is based on a molecule known as mRNA, or messenger RNA, which contains genetic instructions for making proteins inside cells.
The Moderna and Pfizer- BioNTech studies were conducted using slightly different protocols. To be counted as a coronavirus case, participants in the Moderna study had to have at least two symptoms of disease along with a positive test for the virus.
In the Pfizer- BioNTech study, it is required only one symptom.
Also, Moderna waited 14 days following the second injection to begin counting cases, while Pfizer- BioNTech study started counting at seven days.
Another difference in the two vaccines is that both differ in their storage requirements.
Moderna said its vaccine can be safely stored in freezers at around 25 degrees Fahrenheit (-4 degrees Celsius), a temperature easily reached by a home refrigerator freezer.
Pfizer- BioNTech vaccine required storage in specialised ultracold freezers capable of cooling below -94 degrees Fahrenheit (-70 degrees Celsius).
Moderna also said its vaccine would remain potent for up to 30 days at normal refrigerated temperatures, which should ease distribution.
Pfizer and Moderna are still gathering safety data required by the U.S. Food and Drug Administration (FDA) to get an emergency use authorisation that would allow the companies to distribute the vaccine during the pandemic.
For Moderna vaccine, side effects seen at the interim analysis included pain at the injection site, fatigue, and aching muscles and joints. Its data safety and monitoring board did not identify "any significant safety concerns."
Moderna said it plans to file "in the coming weeks" with the FDA for authorisation of the its vaccine for emergency use.
The drugmaker added that it expects to be able to ship about 20 million vaccine doses in the U.S. by the end of 2020. Next year, it said it expects to be able to make 500 million to 1 billion doses worldwide.

Clic here to read the story from its source.